ORGO Q4 2018 Earnings — Organogenesis Holdings Inc. Revenue & Financial Results | Market Cap Arena

ORGOOrganogenesis Holdings Inc.

$338M

Q4 2018 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$64M+865.5% YoY

Gross Profit

$46M72.5% margin

Operating Income

-$4M-7.0% margin

Net Income

-$9M-14.6% margin

EPS (Diluted)

$-0.12

QoQ Revenue Growth

+Infinity%

Cash Flow

Operating Cash Flow

-$60M

Free Cash Flow

-$62M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$164M

Total Liabilities

$117M

Stockholders' Equity

$47M

Cash & Equivalents

$21M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$64M	$7M	+865.5%
Gross Profit	$46M	$5M	+771.4%
Operating Income	-$4M	-$1M	-245.1%
Net Income	-$9M	-$498,107	-1758.0%